Evidence map›Paper›PMID 22739220›Full record

ArticleJournal of clinical gastroenterology2013

Cyclic vomiting associated with excessive dopamine in Riley-day syndrome.

Lucy J Norcliffe-Kaufmann, Felicia B Axelrod, Horacio Kaufmann

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of clinical gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02553265 (Carbidopa in Familial Dysautonomia), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02553265 phase2completednot on this mapstarted 2015, after this paper: background citation

Carbidopa in Familial Dysautonomia: Phase-II Study, Investigational New Drug (IND) 117435, Date: 01/07/13

TypeinterventionalSponsorNYU Langone HealthRan2015 to 2019Enrolled22ConditionsDysautonomia, Familial, Baroreflex Failure SyndromeArmsCarbidopa Low-Dose, Placebo, Carbidopa High-Dose
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Carbidopa: beyond Parkinson's disease.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Review
  6. Article
  7. Familial dysautonomia.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2023
    Review
  8. Article
  9. Gastrointestinal motility disorders in neurologic disease.The Journal of clinical investigation · 2021
    Review
  10. Animal and cellular models of familial dysautonomia.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2017
    Review
  11. Cerebral autoregulation and symptoms of orthostatic hypotension in familial dysautonomia.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
  12. Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2017
    Article
  13. The application of clinical genetics · 2017
    Review
  14. Observational
  15. Article
  16. Brainstem reflexes in patients with familial dysautonomia.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2015
    Article
  17. Current treatments in familial dysautonomia.Expert opinion on pharmacotherapy · 2014
    Review
  18. Disturbances in affective touch in hereditary sensory & autonomic neuropathy type III.International journal of psychophysiology : official journal of the International Organization of Psychophysiology · 2014
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lucy J Norcliffe-KaufmannDepartment of Physiology and Neuroscience, New York University School of Medicine, New York, NY, USA. Horacio.Kaufmann@nyumc.org
Felicia B Axelrod
Horacio Kaufmann
New York University · US

Funding

Training CoreU54NS065736 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BIAGGIONI, ITALO · 2009 to 2018
$11.6M
Carbidopa for the treatment of nausea and vomiting in familial dysautonomiaIND #R01FD003731 · FDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KAUFMANN, HORACIO · 2009 to 2010
$366k
FDA HHS R01 FD003731FDA HHS R01-FD003731-01NINDS NIH HHS U54 NS065736NINDS NIH HHS U54-NS065736-01
6 · The paper itself

Abstract

goalsTo analyze the neurochemical profile during the recurrent attacks of nausea and vomiting in patients with Riley-day syndrome.

backgroundOne of the most disabling features of patients with Riley-day syndrome are recurrent attacks of severe nausea/retching/vomiting accompanied by hypertension, tachycardia, and skin flushing, usually triggered by emotional or other stresses. STUDY: We monitored blood pressure and heart rate and measured plasma catecholamines during typical dysautonomic crises triggered by emotionally charged situations. For comparison, measurements were repeated at follow-up after the symptoms had resolved and the patients were feeling calm and well.

resultsDuring a typical attack, patients were hypertensive and tachycardic. In all patients, circulating levels of norepinephrine (P < 0.002) and dopamine (P < 0.007) increased significantly.

conclusionsActivation of dopamine receptors in the chemoreceptor trigger zone may explain the cyclic nausea/retching/vomiting of patients with Riley-day syndrome.

Indexed as

AdolescentAdultBlood PressureChild, PreschoolDopamineDysautonomia, FamilialEmotionsFemaleHeart RateHumansHypertensionMaleNorepinephrineRecurrenceSympathetic Nervous SystemTachycardiaDopamineNorepinephrine

Identifiers

PMID22739220
PMCPMC6022847
OpenAlexW2058485375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.